Christine E. Brown

City of Hope — United States

Medicine · Health Sciences

64h-index15.5kcitations416works7.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(286), Immunotherapy and Immune Responses(84), Immune Cell Function and Interaction(46), Glioma Diagnosis and Treatment(38), Viral Infectious Diseases and Gene Expression in Insects(38)

Publications415 total

Foundation model cascades enable zero-shot microscopy image analysis for cell therapy manufacturing
Cytotherapy·2026Open Access
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence
Cancer Cell·2025· 2 cited
Label-free in-line characterization of immune cell culture using quantitative phase imaging
npj Regenerative Medicine·2025· 3 citedOpen Access
Supplementary Table S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
Supplementary Table S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
Supplementary Table S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
2025Open Access
First-in-human trial of allogeneic CD6-CAR tregs in patients with chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation
Blood·2025Open Access
TMOD-43. Development of Clinically Relevant Patient-Derived Brain Tumor Models for Advancing Therapeutic Evaluation
Neuro-Oncology·2025Open Access
CTIM-07. A PHASE 1 STUDY OF INTRAVENTRICULARLY ADMINISTERED AUTOLOGOUS HER2-TARGETING CHIMERIC ANTIGEN RECEPTOR T CELLS (HER2-CAR T CELLS), WITH AND WITHOUT LYMPHODEPLETION, IN HER2-POSITIVE BREAST CANCER PATIENTS WITH RECURRENT BRAIN AND/OR LEPTOMENINGEAL METASTASES
Neuro-Oncology·2025Open Access
CTIM-21. PRELIMINARY PERFUSION IMAGING RESULTS FROM PHASE 1 STUDY OF IL13RΑ2-TARGETED CAR-T CELLS FOR LEPTOMENINGEAL BRAIN TUMORS
Neuro-Oncology·2025Open Access
CTIM-20. MR-MEASURED ADC AND FLUID FLOW AS PREDICTORS OF DECREASED PROGRESSION-FREE SURVIVAL IN PRIMARY BRAIN TUMOR PATIENTS RECEIVING IL12RA2 CAR-T THERAPY
Neuro-Oncology·2025Open Access
TMOD-27. Patient-derived glioblastoma organoid cultures for CAR T cell evaluation
Neuro-Oncology·2025Open Access
304 Inducing tumor associated tertiary lymphoid structures using cellular therapy
Regular and Young Investigator Award Abstracts·2025Open Access
EXTH-50. Development of EGFR/IL13Ra2 bispecific CAR T cells to overcome heterogeneous glioblastoma
Neuro-Oncology·2025Open Access
Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic
Nature Biotechnology·2025· 6 cited
page 1 of 21Next →

Frequent Co-authors

Stephen J. Forman(27), Renate Starr(19), Brenda Aguilar(16), Michael C. Jensen(13), Behnam Badie(13), Julie R. Ostberg(12), Xiuli Wang(11), Jamie R. Wagner(9), Michael E. Barish(9), Darya Alizadeh(8), Massimo D’Apuzzo(8), Xin Yang(8), Dongrui Wang(8), Lihong Weng(7), Saul J. Priceman(6), Wen-Chung Chang(6), Araceli Naranjo(5), Jana Portnow(5), Wen-Chung Chang(5), Ryan Urak(5)